Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 12, 2006, Pages 1367-1372

  Ottmani, Salah Eddine ^a   Zignol, M ^a   Bencheikh, N ^b   Laasri L ^b   Chaouki, N ^b   Mahjour, J ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Ministry of Health Morocco   (Morocco)

Author keywords

Retreatment; Treatment outcomes; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOROCCO; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; RETREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MOROCCO; RECURRENCE; RETREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 33845538145     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ottmani S, Laasri L, Chaulet P, et al. La tuberculose et la lutte antituberculose au Maroc de 1980-1998. Rabat, Morocco: Direction de l'Epidémiologie et de Lutte contre les Maladies Bulletin Épidémiologique, 1998; 35: 2-12.
2. Direction de l'Epidémiologie et de Lutte contre les Maladies, Ministère de la Santé. Rapports annuels du Programme national de Lutte anti-tuberculeuse; années 1990 à 2003. Rabat, Morocco: DELM, Ministère de la Santé, 1990-2003.
3. World Health Organization. Global Tuberculosis Control. WHO Report 1997. WHOATB/97.225. Geneva, Switzerland: WHO, 1997.
4. World Health Organization. Global Tuberculosis Control. WHO Report 1998. WHO/TB/98.237. Geneva, Switzerland: WHO, 1998.
5. World Health Organization. Global Tuberculosis Control. WHO Report 1999. WHO/CDS/CPOTB/99.259. Geneva, Switzerland: WHO, 1999.
6. World Health Organization. Global Tuberculosis Control. WHO Report 2000. WHO/CDS/TB/2000.275. Geneva, Switzerland: WHO, 2000.
7. World Health Organization. Global Tuberculosis Control. WHO Report 2001. WHO/CDSATB/2001.287. Geneva, Switzerland: WHO, 2001.
8. World Health Organization. Global Tuberculosis Control. WHO Report 2002. WHO/CDS/TB/2002.295. Geneva, Switzerland: WHO, 2002.
9. World Health Organization. Global Tuberculosis Control. WHO Report 2003. WHO/CDS/TB/2003.316. Geneva, Switzerland: WHO, 2003.
10. World Health Organization. Global Tuberculosis Control. WHO Report 2004. WHO/HTM/TB/2004.331. Geneva, Switzerland: WHO, 2004.
11. World Health Organization. Global Tuberculosis Control. WHO Report 2005. WHO/HTM/TB/2005.349. Geneva, Switzerland: WHO, 2005.
12. World Health Organization. Global Tuberculosis Control. WHO Report 2006. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006.
13. World Health Organization. Forty-fourth World Health Assembly. Resolutions and Decisions. Resolution WHA 44.8. WHA44/1991/REC/1. Geneva, Switzerland: WHO, 1991.
14. Direction de l'Epidémiologie et de Lutte contre les Maladies, Ministère de la Santé. Guide de la lutte anti-tuberculeuse à l'usage des professionnels de santé. Rabat, Morocco: DELM, Ministère de la Santé, 2001.
15. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003.
16. Hong Y P, Kim S J, Lew W J, Lee S H, Lee E K. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994. Int J Tuberc Lung Dis 1998; 2: 365-371.
17. Heldal E, Arnadottir T, Cruz J R, Tardencilla A, Chacon L. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients. Int J Tuberc Lung Dis 2001; 5: 129-136.
18. Cao J P, Zhang L Y, Zhu J Q, Chin D P. Two-year follow-up of directly observed intermittent regimens for smear-positive pul-monary tuberculosis in China. Int J Tuberc Lung Dis 1998; 2: 360-364.
19. World Health Organization. Involving private practitioners in tuberculosis control: issues, interventions and emerging policy framework. WHO/CDS/TB/2001.285. Geneva, Switzerland: WHO, 2001.
20. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/UATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/CDS/TB/2000.278. Geneva, Switzerland: WHO, 2000.
21. Kritski A L, Rodrigues de Jesus L S, Andrade M K, et al. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. Chest 1997; 111: 1162-1167.
22. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545.
23. Becerra M C, Freeman J, Bayona J, et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2000; 4: 108-114.
24. Espinal M A. Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment. Int J Tuberc Lung Dis 2003; 7: 607-608.
25. Quy H T, Lan N T, Borgdorff M W, et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard retreatment regimen adequate? Int J Tuberc Lung Dis 2003; 7: 631-636.
26. Quy H T, Cobelens F G, Lan N T, Buu T N, Lambregts C S, Borgdorff M W. Treatment outcomes by drug resistance, HIV status and treatment regimen among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2005; 10: 45-51.